Clinical trials
Completed Thrombocytopenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
212 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 5 |
| 2004 | 4 |
| 2005 | 16 |
| 2006 | 12 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 14 |
| 2010 | 12 |
| 2011 | 8 |
| 2012 | 8 |
| 2013 | 11 |
| 2014 | 11 |
| 2015 | 10 |
| 2016 | 8 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 12 |
| 2020 | 10 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 212 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 19 |
| GlaxoSmithKline | 18 |
| National Heart, Lung, and Blood Institute (NHLBI) | 11 |
| M.D. Anderson Cancer Center | 7 |
| Eisai Inc. | 5 |
| Novartis Pharmaceuticals | 5 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Shandong University | 4 |
| AO GENERIUM | 3 |
| Christiana Care Health Services | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 212 |
| Purpura, Thrombocytopenic, Idiopathic | 30 |
| Neutropenia | 21 |
| Anemia | 19 |
| Hemorrhage | 14 |
| Myelodysplastic Syndromes | 14 |
| Anemia, Aplastic | 13 |
| Hematologic Diseases | 13 |
| Purpura | 11 |
| Autoimmune Diseases | 9 |
Trials
Showing 1 to 25 of 212. Each trial links to its page on Pharma Observatory.
112 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.